CXCR3 and neoplasm: Together, these results imply that reduced T-cell infiltration into tumors was responsible for the decreased therapeutic effect of CD3xTRP1 in CXCR3 KO mice, suggesting that homing of T cells towards the tumor is necessary for efficacious CD3 bsAb therapy in this “cold” tumor model.